http://www.pluristem.com
Pluristem Therapeutics Inc. Company Intro
Pluristem Therapeutics Inc.’s cell therapy products are designed to treat patients by stimulating their bodies’ own regenerative mechanisms
Industry
Healthcare
Pluristem Therapeutics Inc. Headquaters
Building No. 5
Haifa,31905
Israel
Pluristem Therapeutics Inc. Share price
17 May 2023 13:46 GMT
$0
0.0 (0 %)
Pluristem Therapeutics Inc. Market cap
$
WMC RANKING
2024
Pluristem Therapeutics Inc. # 355
BiotechnologyLatest Pluristem Therapeutics Inc. News
11 Feb 2024
Thérapies cellulaires allogéniques Rapport d'étude de marché 2030, tendances de croissance et concurrence ...
Statsndata de Thérapies cellulaires allogéniques Les rapports d'études de marché fournissent toutes les informations. Il alimente la croissance du marché en...
11 Feb 2024
Thérapies cellulaires allogéniques Rapport d'étude de marché 2030, tendances de croissance et concurrence ...
Statsndata de Thérapies cellulaires allogéniques Les rapports d'études de marché fournissent toutes les informations. Il alimente la croissance du marché en...
11 Feb 2024
Thérapies cellulaires allogéniques Rapport d'étude de marché 2030, tendances de croissance et concurrence ...
Statsndata de Thérapies cellulaires allogéniques Les rapports d'études de marché fournissent toutes les informations. Il alimente la croissance du marché en...
WMC Market Score
WMC Market to Revenue Score
Pluristem Therapeutics Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Pluristem Therapeutics Inc. | USD | $0 | $44,551 | $-43,433 | $ 0.00 | 355 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Pluristem Therapeutics Inc. Social Followers vs Top 4 Industry Competitors
Pluristem Therapeutics Inc. Post vs Top 4 Industry Competitors
Pluristem Therapeutics Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Pluristem Therapeutics Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Pluristem Therapeutics Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Pluristem Therapeutics Inc. | 0.00 | 5.82 | 0.03 | 0 | 0 | 0 | 2.08 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
